标题
Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 2, Pages 205-213
出版商
Future Medicine Ltd
发表日期
2013-01-18
DOI
10.2217/pgs.12.205
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: An analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
- (2012) David C. Landy et al. AMERICAN HEART JOURNAL
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic Therapy
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2012) Edward H. Romond et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
- (2012) Jersey Chen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
- (2011) C. Serrano et al. ANNALS OF ONCOLOGY
- Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer
- (2011) Kathryn F. McGonigle et al. CANCER
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity
- (2011) Hui Cheng et al. CIRCULATION RESEARCH
- Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
- (2011) Luigi Tarantini et al. JOURNAL OF CARDIAC FAILURE
- Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
- (2011) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomic insights into chronic anthracycline cardiotoxicity
- (2011) Martin Štěrba et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Acute Mesenteric Infarction Associated with Atrial Fibrillation
- (2011) Jia-Ming Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is cardiotoxicity being adequately assessed in current trials of cytotoxic and targeted agents in breast cancer?
- (2010) S. Verma et al. ANNALS OF ONCOLOGY
- Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues
- (2010) Alberto Zambelli et al. BREAST
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure
- (2010) Brian C. Jensen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies
- (2010) Geoffrey J. Yoon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer
- (2010) F. Montemurro et al. ONCOLOGIST
- Cardiotoxicity Associated with Targeting Kinase Pathways in Cancer
- (2010) Howard R. Mellor et al. TOXICOLOGICAL SCIENCES
- Trastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study
- (2009) Maya Guglin et al. JOURNAL OF CARDIAC FAILURE
- Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
- (2009) Masashi Yoshida et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
- (2009) Vladan Rajić et al. LEUKEMIA & LYMPHOMA
- Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
- (2009) Emanuel Raschi et al. PHARMACOLOGY & THERAPEUTICS
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac-Targeted Expression of Soluble Fas Attenuates Doxorubicin-Induced Cardiotoxicity in Mice
- (2008) J. Niu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started